JCLGX
Price
$15.24
Change
+$0.03 (+0.20%)
Updated
Aug 8 closing price
Net Assets
8.46B
JTLGX
Price
$15.36
Change
+$0.03 (+0.20%)
Updated
Aug 8 closing price
Net Assets
8.46B
Interact to see
Advertisement

JCLGX vs JTLGX

Header iconJCLGX vs JTLGX Comparison
Open Charts JCLGX vs JTLGXBanner chart's image
JHancock Multimanager Lifestyle Gr C
Price$15.24
Change+$0.03 (+0.20%)
VolumeN/A
Net Assets8.46B
JHancock Multimanager Lifestyle Gr R5
Price$15.36
Change+$0.03 (+0.20%)
VolumeN/A
Net Assets8.46B
JCLGX vs JTLGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JCLGX vs. JTLGX commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCLGX is a Hold and JTLGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JCLGX (8.46B) and JTLGX (8.46B) have equal amount of cash in the bank . JTLGX pays higher dividends than JCLGX: JTLGX (2.15) vs JCLGX (1.20). JCLGX was incepted earlier than JTLGX: JCLGX (20 years) vs JTLGX (20 years). JCLGX (2.08) is less costly to investors than JTLGX (1.02). JCLGX (13.00) and JTLGX (13.00) have comparable annual turnover. JTLGX has a lower initial minimum investment than JCLGX: JTLGX (0) vs JCLGX (1000). JTLGX annual gain was more profitable for investors over the last year : 13.07 vs. JCLGX (11.95). JTLGX return over 5 years is better than : 13.42 vs. JCLGX (8.54).
JCLGXJTLGXJCLGX / JTLGX
Total Expense Ratio2.081.02204%
Annual Report Gross Expense Ratio2.081.02204%
Fund Existence20 years20 years-
Gain YTD7.7208.41692%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.46B8.46B100%
Annual Yield % from dividends1.202.1556%
Returns for 1 year11.9513.0791%
Returns for 3 years10.9213.8779%
Returns for 5 years8.5413.4264%
Returns for 10 years-0.337.48-4%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX41.45N/A
N/A
Rydex Biotechnology C
PHSKX59.97N/A
N/A
Virtus KAR Mid-Cap Growth A
BRUFX524.86N/A
N/A
Bruce
CUSUX18.95N/A
N/A
Six Circles U.S. Unconstrained Equity
JORNX20.32-0.03
-0.15%
Janus Henderson Global Select T